TWC
FENC icon

TD Waterhouse Canada’s Fennec Pharmaceuticals FENC Stock Holding History

TD Waterhouse Canada’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$173 Hold
29
– – ﹤0.01% 2193
2025
Q4 		$223 Hold
29
– – ﹤0.01% 1936
2025
Q3 		$231 Buy
29
+11
+61% +$95 ﹤0.01% 1961
2025
Q2 		$149 Buy
+18
New +$123 ﹤0.01% 1896
2022
Q1 		– Sell
-555
Closed -$2.5K – 1807
2021
Q4 		$2.5K Buy
+555
New +$4.13K ﹤0.01% 1560

Other funds holding FENC

RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Potomac Capital Management New York $115M AUM

TD Waterhouse Canada's FENC Position: Q1 2026 in Review

TD Waterhouse Canada held its Fennec Pharmaceuticals (FENC) position steady in Q1 2026 at 29 shares worth $173. The position accounts for ﹤0.01% of the portfolio, ranked #2193.

TD Waterhouse Canada first reported a position in FENC in Q4 2021 and has held it in 5 quarters since. The position peaked at $2.5K in Q4 2021. 90 funds tracked by Wall St. Rank hold FENC as of Q1 2026.

  • TD Waterhouse Canada held 29 shares of Fennec Pharmaceuticals worth $173 as of Q1 2026.
  • TD Waterhouse Canada left its Fennec Pharmaceuticals share count unchanged in Q1 2026.
  • Fennec Pharmaceuticals made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q1 2026, its #2193 holding.
  • TD Waterhouse Canada first reported a position in Fennec Pharmaceuticals in Q4 2021 and has held it in 5 quarters since.
  • TD Waterhouse Canada's Fennec Pharmaceuticals position peaked at $2.5K in Q4 2021.
  • 90 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q1 2026.

Based on TD Waterhouse Canada's 13F filing for Q1 2026, filed 12 May 2026.